Muscle Invasive Bladder Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
- $ 2500
- April 2024
- 171 pages
Advanced Malignancy, Bile Duct Cancer (Cholangiocarcinoma) , Bladder Cancer, Breast Cancer, Cervical Cancer, Colorectal Cancer, Endometrial Cancer, Fallopian Tube Cancer, Gastric Cancer, Gastroesophageal (GE) Junction Carcinomas, Gynecological Cancer, Metastatic Adenocarcinoma of The Pancreas, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Metastatic Pancreatic Cancer, Metastatic Transitional (Urothelial) Tract Cancer, Muscle Invasive Bladder Cancer (MIBC), Ovarian Cancer, Pancreatic Cancer, Peripheral Nerve Sheath Tumor (Neurofibrosarcoma), Peritoneal Cancer, Prostate Cancer, Small-Cell Lung Cancer, Solid Tumor, Transitional Cell Cancer (Urothelial Cell Cancer), Triple-Negative Breast Cancer (TNBC), Ureter Cancer, Urethral Cancer [...] Adenocarcinoma Of The Gastroesophageal Junction, Bile Duct Cancer (Cholangiocarcinoma) , Biliary Tumor, Bladder Cancer, Breast Cancer, Colorectal Cancer, Endometrial Cancer, Esophageal Cancer, Gallbladder Cancer, Gastric Cancer, Gastrointestinal Tumor, Gynecological Cancer, Human Epidermal Growth Factor Receptor ## Positive Breast Cancer (HER2+ Breast Cancer), Melanoma, Metastatic Breast Cancer, Muscle Invasive Bladder Cancer (MIBC), Pancreatic